In what researchers have called an “unprecedented” response, a new drug that treats locally advanced rectal cancer has shown to have completely eradicated tumors in all 42 patients who took part in the Phase II trial.

While still in its early stages before clinical use, it’s already been hyped up as a ‘wonder drug’ for successful, non-invasive cancer treatment.